Strategy
For the definition of our strategy, we have set ten priority objectives in order to conduct our actions within a global context, while taking into account ever-changing health challenges.
Strategic objectives
A long-term global health ambition
- Define, promote and fund:
- a national and international research programme with the ultimate goal of eliminating HIV, sexually transmitted infections, viral hepatitis and tuberculosis.
- a national and international research programme on the prevention, early detection, treatment, and surveillance of emerging and re-emerging infectious diseases, based on the One Health approach.
- Promote the uptake of research findings into clinical and public health tools, such as diagnostic tools, vaccines, treatments and non-pharmaceutical interventions.
A philosophy of openness and collaboration
- Develop and strengthen national, European and international stakeholder networks and partnerships, with the inclusion of civil society and affected populations.
- Drive and coordinate the French scientific community to facilitate the creation of ambitious research projects and programmes; expand the boundaries of knowledge and prepare the scientific agenda of the future.
- Implement the effective communication of research and its findings to all stakeholders, including health authorities, international organisations, affected communities and the media.
Agility and adaptability today and tomorrow
- Set up a flexible administrative and scientific organisation enabling us to respond rapidly and conduct research to address infectious disease emergencies.
- Adapt our organisation to meet emerging needs in terms of health diplomacy, equity, inclusion, diversity, and climate and environmental change.
Ethical and societal commitment: support integrated and inclusive research
- Conduct ethical research that ensures the well-being of the participants and affected communities, and that improves local training, capabilities and infrastructures.
- Support and promote the participation and development of young researchers and defend and develop parity.
- Advocate for research and increased national/international funding to support research into HIV, sexually transmitted infections, viral hepatitis, tuberculosis and emerging infectious diseases.
Continuum of crisis preparedness and response
Our mandate to support research is part of a continuum and covers two complementary aspects:
- The rapid implementation of research programmes in the event of an emergence: we have developed a framework to systematically respond to emerging infectious disease epidemics (in France and abroad), based on grading the response according to the specific characteristics of the emergence: type of pathogen, location, risk of extension and whether or not medical countermeasures exist.
- Long-term preparedness for future epidemics and pandemics: we participate in two strategic programmes:
- in France, we contribute to the emerging infectious diseases and chemical, biological, radiological and nuclear (CBRN) threats national acceleration strategy supported by the France 2030 investment plan through the operational management of the Emerging Infectious Diseases Priority Research and Resources Programme (PEPR MIE).
- in Europe, we coordinate the BE READY (CSA-BE READY) project, with the aim of federating over 20 European partners around the preparation of a research agenda for emerging crises.
Emergence programme
In the event of an emerging or re-emerging epidemic in France or worldwide, our agency can activate a facilitation and watch procedure for a rapid response to health crises.
Emerging Infectious Diseases PEPR
Emerging and re-emerging infectious diseases are a public health priority. The recent COVID-19 pandemic is a concrete illustration of the impact of such diseases on health but also on economies and societies. In this context, the implementation of ambitious research projects is essential if we are to better understand, prevent and control the phenomena of emergence of infectious diseases.